Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-25T15:26:03.008Z Has data issue: false hasContentIssue false
  • English
  • Français

The Wellcome Trust Lecture: Infection and disease in lymphatic filariasis: an immunological perspective

Published online by Cambridge University Press:  06 April 2009

E. A. OtteSen
E. A. OtteSen
Affiliation:
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 20892, USA
Get access Rights & Permissions [Opens in a new window]

Summary

The basic tenet of the immunological perspective of fuiarial disease is that differential immune responsiveness among individuals exposed to infection results in the different clinical manifestations that develop. The mechanisms involved in this differential responsiveness appear to reflect different T-cell cytokine response patterns. Asymptomatic patients with the clinically silent presentation of ‘asymptomatic microfilaraemia’, who have been previously described as being ‘immunosuppressed’ with respect to their generating pro-inflammatory (Th1-type) immune responses to parasite antigen, are now recognized to be fully responsive to parasite antigen but to produce cytokines and mediators that have primarily anti-inflammatory (Th2-like) effects. Studies with immunodeficient mice have indicated the existence of two alternative pathways to the development of lymphatic pathology: one dependent on the induction of inflammatory reactions by the host immune response, the other entirely independent of the immune system and reflecting the direct actions of the parasite or its products on the lymphatics. As histopathology of affected human lymphatics is consistent with this hypothesis, it may be that the lymphatic pathology seen normally in the amicrofilaraemic, highly immunoresponsive infected patients derives from inflammation induced by immune responses to parasite antigen, whereas the lymphatic pathology sometimes seen coexisting with the ‘immunosuppressed’ state of asymptomatic microfilaraemia actually reflects lymphatic damage that is not immunologically mediated. Though little information exists about the ‘natural history’ of lymphatic filariasis, there is no evidence for an inevitable progression from one clinical form to another. Instead, there appears to be a definite plasticity in the response that depends on prior (? pre-natal) and current exposure to the parasite as well as on the immunomodulatory effects it induces. This plasticity does not appear to be complete, however, as there is no evidence that a chronically infected host who has developed strong pro-inflammatory immune responses can subsequently become sufficiently ‘down-regulated’ to support an asymptomatic microfilaraemia type of infection. Another possible constraint to the plasticity of the clinical and immunological responses may be the genetic determination of certain unusual syndromes, such as tropical pulmonary eosinophilia or TPE, though this hypothesis remains to be proven.

Keywords

lymphaticfilariasisimmunological perspectivediseaseinfection.
Type
Lymphatic Filariasis
Information
Parasitology , Volume 104 , Issue S1: Symposia of the British Society for Parasitology Volume 29:Human parasitic disease: the complementory roles of field and laboratory studies , June 1992 , pp. S71 - S79
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Bundy, D. A. P., Grenfell, B. T. & Rajagopalan, P. K. (1991). Immunoepidemiology of lymphatic filariasis: the relationship between infection and disease. In Immunoparasitology Today (ed. Ash, C. & Gallagher, R. B.) pp. A71–A76. Cambridge: Elsevier Trends Journals.Google Scholar
Chan, S. H., Dissanayake, S., Mak, J. W., Ismail, M. M., Wee, G. B., Srinivasan, N., Soo, B. H. & Zaman, V. (1984). HLA and filariasis in Sri Lankans and Indians. Southeast Asian Journal of Tropical Medicine and Public Health 15, 281–6.Google ScholarPubMed
Denham, D. A., Ponnudurai, T., Nelson, G. S., Rogers, R. & Guy, F. (1972). Studies with Brugia pahangi. II. The effect of repeated infection on parasite levels in cats. International Journal for Parasitology 2, 401–7.CrossRefGoogle ScholarPubMed
Dreyer, G., Ottesen, E. A., Galdino, E., Andrade, L., Rocha, A., Medeiros, Z., Moura, I., Casimiro, I., Bellz, F. & Couthinho, A. (1992). Renal abnormalities in microfilaremic patients with bancroftian filariasis. American Journal of Tropical Medicine and Hygiene (in the Press).CrossRefGoogle ScholarPubMed
Grenfell, B. T., Michael, E. & Denham, D. A. (1992). The cat-Brugia pahangi system as a model for the dynamics of human lymphatic filariasis. Parasitology Today (in the Press).Google Scholar
Gyorkos, T. W., Sukul, N. C. & Dasdal, A. (1983). Filariasis and ABO blood status: a critical appraisal. Transactions of the Royal Society of Tropical Medicine and Hygiene 17, 564–5.CrossRefGoogle Scholar
Hussain, R., Grogl, M. & Ottesen, E. A. (1987). IgG antibody subclasses in human filariasis. Differential subclass recognition of parasite antigens correlates with different clinical manifestations of infection. Journal of Immunology 139, 2794–8.CrossRefGoogle ScholarPubMed
Hussain, R., Poindexter, R. W. & Ottesen, E. A. (1992). Control of allergic reactivity in human filariasis: Predominant localization of blocking antibody to the IgG4 subclass. Journal of Immunology (in the Press).CrossRefGoogle Scholar
Klei, T. R., Blanchard, D. P. & Coleman, S. U. (1986). Development of Brugia pahangi infections and lymphatic lesions in male offspring of female jirds with homologous infections. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 214–16.CrossRefGoogle ScholarPubMed
Lal, R. B., Kumaraswami, V., Steel, C. & Nutman, T. B. (1990). Phosphocholine-containing antigens of Brugia malayi nonspecifically suppress lymphocyte function. American Journal of Tropical Medicine and Hygiene 42, 56–64.CrossRefGoogle ScholarPubMed
Lammie, P. J., Hitch, W. L., Allen, E. M. W., Hightower, W. & Eberhard, M. L. (1991). Maternal filarial infection as risk factor for infection in children. Lancet 337, 1005–6.CrossRefGoogle ScholarPubMed
Miller, S., Snowden, K., Schreuer, D. & Hammerburg, B. (1990). Selective breeding of dogs for segregation of limb edema from rnicrofilaremia as clinical manifestations of Brugia infections. American Journal of Tropical Medicine and Hygiene 43, 489–97.CrossRefGoogle ScholarPubMed
Nutman, T. B., Kumaraswami, V. & Ottesen, E. A. (1987 a). Parasite-specific energy in human fIlariasis. Insights after analysis of parasite antigen-driven lymphokine production. Journal of Clinical Investigation 79, 1516–23.CrossRefGoogle Scholar
Nutman, T. B., Kumaraswami, V., Pao, L., Narayanan, P. R. & Ottesen, E. A. (1987 b). An analysis of in vitro B cell immune responsiveness in human lymphatic filariasis. Journal of Immunology 138, 3954–9.CrossRefGoogle ScholarPubMed
Nutman, T. B., Miller, K. D., Mulligan, M. & Ottesen, E. A. (1986). Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. Journal of Infectious Diseases 154, 10–18.CrossRefGoogle ScholarPubMed
Nutman, T. B., Ottesen, E. A., Fauci, A. S. & Volkman, D. J. (1984). Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function. Journal of Clinical Investigation 73, 1754–62.CrossRefGoogle Scholar
Ottesen, E. A. (1980). Immunopathology of lymphatic filariasis in man. Springer Seminars in Imnzunopathology 2, 373–85.Google Scholar
Ottesen, E. A. (1984). Immunological aspects of lymphatic filariasis and onchocerciasis in man. Transactions of the Royal Society of Tropical Medicine and Hygiene 78 (Suppl.), 9–18.CrossRefGoogle ScholarPubMed
Ottesen, E. A. (1989). Filariasis now. American Journal of Tropical Medicine and Hygiene 41 (Suppl.), 9–17.CrossRefGoogle ScholarPubMed
Ottesen, E. A. (1990). The filariases and tropical pulmonary eosinophilia. In Tropical and Geographical Medicine (ed. Warren, K. S. & Mahmoud, A. A. F.), pp. 407–428. New York: McGraw-Hill.Google Scholar
Ottesen, E. A., Mendell, N. R., MacQueen, J. M., Weller, P. F., Amos, D. B. & Ward, F. E. (1981). Familial predisposition to filarial infection – not linked to HLA-A or -B locus specificities. Acta Tropica 38, 205–16.Google ScholarPubMed
Ottesen, E. A. & Nutman, T. B. (1992). Tropical pulmonary eosinophilia. Annual Reviews of Medicine 43, 418–424.CrossRefGoogle ScholarPubMed
Ottesen, E. A., Skvaril, F., Tripathy, S. P., Poindexter, R. W. & Hussain, R. (1985). Prominence of IgG4 in the IgG antibody response to human filariasis. Journal of Immunology 134, 2707–12.CrossRefGoogle ScholarPubMed
Ottesen, E. A., Weller, P. F. & Heck, L. (1977). Specific cellular immune unresponsiveness in human filariasis. Immunology 33, 413–21.Google ScholarPubMed
Ottesen, E. A., Weller, P. F., Lunde, M. N. & Hussain, R. (1982). Endemic filariasis on a Pacific Island. II. Immunologic aspects: immunoglobulin, complement, and specific antifilarial IgG, 1gM, and LgE antibodies. Anzerican Journal of Tropical Medicine and Hygiene 31, 953–61.CrossRefGoogle Scholar
Partono, F., Purnomo, , Pribadi, W. & Soewarta, A. (1978). Epidemiological and clinical features of Brugia timori in a newly established village, Karakuak, West Flores, Indonesia. American Journal of Tropical Medicine and Hygiene 27, 910–15.CrossRefGoogle Scholar
Piessens, W. F., McGreevy, P. B., Piessens, P. W., McGreevy, M., Koiman, I., Saroso, J. S. & Dennis, D. T. (1980). Immune responses in human infections with Brugia malayi. Specific cellular unresponsiveness to filarial antigens. Journal of Clinical Investigations 65, 172–9.CrossRefGoogle ScholarPubMed
Plaisir, A. P., Van Oortmarssen, C. J., Habbema, J. D. F., Remme, J. & Alley, E. S. (1990). ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Computer Methods and Programs in Biomedicine 31, 43–56.CrossRefGoogle Scholar
Suswillo, R. R., Doenhoff, M. J. & Denham, D. A. (1981). Successful development of Brugia pahangi in T-cell deprived CBA mice. Acta Tropica 38, 305–8.Google ScholarPubMed
Vanamail, P., Subramanian, S., Das, P. K., Pani, S. P., Rajagopalan, P. K., Bundy, D. A. P. & Grenfell, B. T. (1989). Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Transactions of the Royal Society of Tropical Pvledicine and Hygiene 83, 689–93.CrossRefGoogle ScholarPubMed
Vickery, A. C., Albertine, K. H., Nayar, J. K. & Kwa, B. H. (1991). Histopathologv of Brugia malayi infected nude mice after immune-reconstitution. Acta Tropica 49, 45–55.CrossRefGoogle ScholarPubMed
Vincent, A. L., Vickery, A. C., Lotz, M. J. & Desai, U. (1984). The lymphatic pathology of Brugia pahangi in nude (athymic) and thymic mice C3H/HeN. Journal of Parasitology 70, 48–56.CrossRefGoogle ScholarPubMed
Von Lichtenberc, F. (1987). The Wellcome Trust lecture. Inflammatory responses to filarial connective tissue parasites. Parasitology 94 (Suppl) 5, 101–122.CrossRefGoogle Scholar
Wadee, A. A., Vickery, A. C. & Piessens, W. F. (1987). Characterization of immunosuppressive proteins of Brugia malayi microfilariae. Acta Tropica 44, 343–52.Google ScholarPubMed
Wartman, W. B. (1947). Filariasis in American armed forces in World War II. Medicine 12, 181–9.Google Scholar
World Health Organization (1984). Filariasis – Report of the Fourth Expert Committee. World Health Organization Technical Report Series No. 702, p. 112.Google Scholar